AMYLIN PHARMACEUTICALS INC Financing Cash Flow
AMYLIN PHARMACEUTICALS INC reported Financing Cash Flow of $229.15 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-08-03.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2012-08-03
- AMYLIN PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2012-06-30 was $24.20M.
- AMYLIN PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2012-03-31 was $204.95M, a 4634.44% increase year-over-year.
- AMYLIN PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2011-12-31 was $527.00K.
- AMYLIN PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2011-09-30 was $2.90M.
- AMYLIN PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2011 was -$26.18M.
- AMYLIN PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2010 was -$77.25M.
- AMYLIN PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2009 was -$20.29M, a 221.53% decline from fiscal 2008.
- AMYLIN PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2008 was $16.69M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2012-06-30 | $24.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $229.15M 10-Q · filed 2012-08-03 | $229.68M derived: sum of 3 quarters · filed 2012-08-03 | $232.58M derived: sum of 4 quarters · filed 2012-08-03 |
| 2012-03-31 | $204.95M 10-Q · filed 2012-05-07 | $205.48M derived: sum of 2 quarters · filed 2012-05-07 | $208.38M derived: sum of 3 quarters · filed 2012-05-07 | $174.45M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-12-31 | $527.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $3.42M derived: sum of 2 quarters · filed 2012-02-22 | -$30.51M derived: sum of 3 quarters · filed 2012-08-03 | -$26.18M 10-K · filed 2012-02-22 |
| 2011-09-30 | $2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | -$31.04M derived: sum of 2 quarters · filed 2012-08-03 | -$26.71M 10-Q · filed 2011-10-28 | -$95.75M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-06-30 | -$33.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | -$29.60M 10-Q · filed 2012-08-03 | -$98.65M derived: sum of 3 quarters · filed 2012-08-03 | -$101.79M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-03-31 | $4.33M 10-Q · filed 2012-05-07 | -$64.72M derived: sum of 2 quarters · filed 2012-05-07 | -$67.86M derived: sum of 3 quarters · filed 2012-05-07 | -$72.27M derived: sum of 4 quarters · filed 2012-05-07 |
| 2010-12-31 | -$69.05M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | -$72.19M derived: sum of 2 quarters · filed 2012-02-22 | -$76.60M derived: sum of 3 quarters · filed 2012-02-22 | -$77.25M 10-K · filed 2012-02-22 |
| 2010-09-30 | -$3.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | -$7.55M derived: sum of 2 quarters · filed 2011-10-28 | -$8.20M 10-Q · filed 2011-10-28 | -$15.98M derived: sum of 4 quarters · filed 2012-02-22 |
| 2010-06-30 | -$4.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | -$5.06M 10-Q · filed 2011-08-08 | -$12.83M derived: sum of 3 quarters · filed 2012-02-22 | -$14.11M derived: sum of 4 quarters · filed 2012-02-22 |
| 2010-03-31 | -$651.00K 10-Q · filed 2011-05-05 | -$8.42M derived: sum of 2 quarters · filed 2012-02-22 | -$9.71M derived: sum of 3 quarters · filed 2012-02-22 | |
| 2009-12-31 | -$7.77M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | -$9.05M derived: sum of 2 quarters · filed 2012-02-22 | -$20.29M 10-K · filed 2012-02-22 | |
| 2009-09-30 | -$1.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | -$12.52M 10-Q · filed 2010-11-08 | ||
| 2009-06-30 | -$11.23M 10-Q · filed 2010-08-05 | |||
| 2008-12-31 | $16.69M 10-K · filed 2011-02-25 |